PAM
GBIO

Panagora Asset Management’s Generation Bio GBIO Stock Holding History

Panagora Asset Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,637
Closed -$35K – 1148
2025
Q1 		$35K Sell
8,637
-127
-1% -$892 ﹤0.01% 1094
2024
Q4 		$92.9K Buy
8,764
+11
+0.1% +$196 ﹤0.01% 1117
2024
Q3 		$216K Sell
8,753
-9
-0.1% -$238 ﹤0.01% 1128
2024
Q2 		$247K Sell
8,762
-32
-0.4% -$1.04K ﹤0.01% 1088
2024
Q1 		$358K Buy
8,794
+5,830
+197% +$137K ﹤0.01% 1041
2023
Q4 		$48.9K Buy
+2,964
New +$51.7K ﹤0.01% 1213
2023
Q1 		– Sell
-5,861
Closed -$230K – 1479
2022
Q4 		$230K Buy
+5,861
New +$308K ﹤0.01% 1347

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Panagora Asset Management's GBIO Position: Q2 2025 in Review

Panagora Asset Management sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 8,637 shares — an estimated $35K sold.

Panagora Asset Management first reported a position in GBIO in Q4 2022 and held it in 7 quarters. The position peaked at $358K in Q1 2024. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

  • Panagora Asset Management reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
  • Panagora Asset Management sold 8,637 Generation Bio shares in Q2 2025, an estimated $35K.
  • Panagora Asset Management first reported a position in Generation Bio in Q4 2022 and held it in 7 quarters.
  • Panagora Asset Management's Generation Bio position peaked at $358K in Q1 2024.
  • 61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on Panagora Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.